Previously recorded videos may contain expired pricing, exclusivity claims, or promotional offers.
Back to video

Perricone Neuropeptide Resurfacing Cleanse & Tone Duo

£49.92
Deleted £72.00 Save 30%

In Stock

Available on Waitlist

Sold Out

We're sorry.We're sorry, this product is not available at this time. Use the search bar to find similar items.

This item is available through Advanced Order. It will be shipped the week commencing .

Wait Cancel

Low Stock

Quantity:

Half price P&P on every additional item.

Offer details
Added to the Wishlist !

Refresh your skincare ritual with this Perricone Neuropeptide Resurfacing Cleanse & Tone duo, pairing a creamy cleanser with a lightweight toner to help leave your skin looking smoother and more refined. Ideal for morning or evening use, these formulas work together to help lift away impurities and leave your complexion feeling fresh and comfortable with a beautifully polished finish.

Science-led innovation - formulated by world-renowned dermatologist and nutritionist Dr. Nick Perricone, this scientifically formulated skincare range features innovative treatments to help tackle visible signs of ageing. If you know what you want from your skincare and are searching for products at the cutting edge of the beauty industry, this duo is for you.

Contains:
  • 1 x Neuropeptide Pore-Refining & Resurfacing Cream Cleanser (177ml) - creamy cleanser designed to gently exfoliate and help remove impurities and dead surface cells
  • 1 x High Potency Face Finishing & Firming Toner (118ml) - lightweight rose-scented toner designed to help smooth the look of skin texture and refine the appearance of pores

How to use:
Neuropeptide Pore-Refining & Resurfacing Cream Cleanser
  • Apply to damp skin and massage gently onto your face
  • Rinse
High Potency Face Finishing & Firming Toner
  • Apply after cleansing using a cotton pad or your hands, avoiding your eye area

Complete Your Look

Other Customers Also Bought

Recommended For You

Your Recently Viewed Items

Reviews & Customer Q&A